title: Efficacy of nonsurgical therapy for urinary incontinence.
abstract: OBJECTIVE
  to assess the efficacy of aggressive nonsurgical therapy for urinary incontinence in women and to determine if it is advantageous to perform invasive urodynamic testing prior to initiating treatment.
  
  
  METHODS
  We subjectively assessed 202 incontinent women three months to four years following nonsurgical therapy for urinary incontinence. Therapy in all patients included behavioral modification in the form of timed voiding and pelvic floor exercises. Depending on the suspected diagnosis and menopausal state, patients were also treated with various combinations of pharmacologic agents and estrogen replacement therapy. Based on initial evaluation, patient preference and referring physician preference, 100 women were started on therapy after a minimal evaluation, while 102 women were treated based on invasive urodynamic testing. A subjective assessment of treatment outcome was made via a telephone interview in which patients were asked standardized questions.
  
  
  RESULTS
  One hundred nineteen cases (59%) were subjectively improved or cured with nonsurgical therapy. Performing urodynamic testing prior to initiating therapy did not increase the overall success rate: 69 of 100 patients (69%) treated on the basis of history, physical examination and a minimal office evaluation were improved or cured, while only 50 of 102 patients (49%) having electronic multichannel urodynamic testing were improved or cured.
  
  
  CONCLUSIONS
  All women with urinary incontinence should be initially offered nonsurgical therapy since a large percentage will obtain satisfactory results. It is not beneficial or cost-effective to perform electronic urodynamic testing prior to initiating therapy.
authors.affiliation: Department of Obstetrics and Gynecology, Good Samaritan Hospital, University of Cincinnati, Ohio 45220, USA.
authors.forename: M M
authors.initials: MM
authors.lastname: Karram
authors.forename: L
authors.initials: L
authors.lastname: Partoll
authors.forename: J
authors.initials: J
authors.lastname: Rahe
mesh_terms: D001519:Behavior / Q000502:physiology; D003131:Combined Modality Therapy; D003362:Cost-Benefit Analysis; D015914:Estrogen Replacement Therapy / Q000592:standards; D005260:Female; D006801:Humans; D008875:Middle Aged; D017773:Pelvic Floor / Q000502:physiology; D016896:Treatment Outcome; D014549:Urinary Incontinence / Q000503:physiopathology / Q000628:therapy*; D014554:Urination / Q000502:physiology; D014563:Urodynamics / Q000502:physiology